HealWell AI and WELL Health Technologies have jointly introduced WellTrust, an AI-driven platform designed to improve clinical trial recruitment while prioritizing ethics, transparency, and patient privacy. WellTrust uses advanced AI to match eligible patients with suitable trials more efficiently, reducing recruitment delays and enhancing diversity while embedding strict safeguards to ensure informed consent, bias mitigation, and compliance with global regulations.
Glimpse:
WellTrust leverages HealWell’s AI capabilities and WELL Health’s extensive primary care network to identify trial candidates from real-world patient data. It automates eligibility screening, provides personalized trial recommendations, and streamlines enrollment workflows all with built-in ethical controls such as patient-first consent processes, anonymized data handling, and transparent decision explainability. The platform aims to cut recruitment timelines by up to 50%, improve participant diversity, and rebuild trust in clinical research by putting ethics and patient autonomy first.
HealWell AI and WELL Health Technologies have officially launched WellTrust, a next-generation AI platform created specifically to address longstanding challenges in clinical trial patient recruitment. The solution combines HealWell’s proven AI expertise in healthcare analytics with WELL Health’s vast network of primary care clinics across Canada, enabling more accurate, faster, and ethically sound identification of trial participants.
WellTrust works by analyzing structured and unstructured patient data (with explicit consent) to match individuals against trial inclusion/exclusion criteria. It then surfaces personalized trial opportunities to both patients and their primary care providers, offering clear explanations of benefits, risks, eligibility, and next steps. Key ethical features include:
Granular, revocable consent patients control exactly what data is used and can withdraw permission at any time Bias detection & mitigation continuous monitoring to prevent underrepresentation of marginalized groups Explainable AI every match or recommendation includes transparent reasoning so clinicians and patients understand the “why” Privacy-by-design fully compliant with HIPAA, PIPEDA, GDPR, and upcoming Canadian health data rules Human oversight no automated enrollment; all final decisions rest with patients and providers
Early results from pilot deployments show significant improvements: faster screening, higher enrollment rates among underrepresented populations, reduced site burden, and stronger patient trust due to the platform’s transparency. The collaboration aims to scale WellTrust across WELL Health’s 165+ clinics and eventually partner with additional research networks and sponsors.
This launch reflects growing industry recognition that ethical AI is not just a compliance checkbox it is essential for rebuilding public confidence in clinical trials and ensuring more equitable access to investigational therapies.
“Recruitment should never come at the cost of trust. WellTrust puts patients first using AI responsibly to connect people with trials they actually qualify for and want to join.”
By
HB Team
Related News
